As Canada-US trade-war draws nigh, so does the threat to nationalise US pharma patents

Last June, U of Ottawa law professor/biomedical scientist Amir Attaran floated the idea of invalidating US pharma patents as a way for Canada to retaliate against trade attacks by the Trump administration. (more…)